WE HAVE A CLINICAL TRIAL OPEN AND ENROLLING

  • 7
  • 0

A Study of Tersolisib (LY4064809/​STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NCT07174336

Any patient who has advanced (stage 4) breast cancer and their cancer is hormon receptor positive and her2 negative, can be a candidate.

Participants will benefit from state of the art cancer therapy regardless of their insurance.

They will receive cancer therapy and imgaing and lab and be cared for with the NOVA Oncology team.

Please contact us if you or you know someone who might benefit from this clinical trial

956-234-4677

Add Comment

Your email address will not be published. Required fields are marked *